These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 9952062)

  • 1. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
    Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
    Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and visual source memory deficits among ecstasy/polydrug users.
    Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C
    Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI; Hoshi R; Talbot AC
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
    Guillot C
    J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
    Cowan RL; Lyoo IK; Sung SM; Ahn KH; Kim MJ; Hwang J; Haga E; Vimal RL; Lukas SE; Renshaw PF
    Drug Alcohol Depend; 2003 Dec; 72(3):225-35. PubMed ID: 14643939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.